Cite
HARVARD Citation
Miyashita, Y. et al. (2021). Impact of the generation of EGFR‐TKIs administered as prior therapy on the efficacy of osimertinib in patients with non‐small cell lung cancer harboring EGFR T790M mutation. Thoracic cancer. 12 (3), pp. 329-338. [Online].